Effectively managing drug safety operations across multiple vendors is crucial to ensure compliance with safety reporting regulations and maintain trial integrity. Implementing standardized data formats, establishing a consistent onboarding process, and consolidating safety vendors can help mitigate challenges associated with disparate data and processes. Early and frequent communication among clinical operations, safety vendors, and regulators is essential for a cohesive and compliant drug safety program.
